HOXB13 suppresses de novo lipogenesis through HDAC3-mediated epigenetic reprogramming
X. Lu, K. W. Fong, G. Gritsina, F. Wang, S. C. Baca, J. Berchuck, J. Ross, E. Corey, W. Catalona, N. S. Chandel, X. Yang, M. L. Freedman, J. C. Zhao, J. Yu
This study identifies HOXB13's AR-independent role in suppressing lipogenesis via HDAC3-mediated epigenetic repression, linking its loss to metastatic prostate cancer progression.
bioRxiv · Oct 4, 2021Cancer Biology